Miyano Kei, Ueno Noriko, Takeya Ryu, Sumimoto Hideki
Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582; CREST, Japan Science and Technology Agency, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan.
Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582.
J Biol Chem. 2006 Aug 4;281(31):21857-21868. doi: 10.1074/jbc.M513665200. Epub 2006 Jun 8.
Activation of the non-phagocytic superoxide-producing NADPH oxidase Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1. However, the role of the small GTPase Rac remained to be clarified. Here we show that Rac directly participates in Nox1 activation via interacting with Noxa1. Electropermeabilized HeLa cells, ectopically expressing Nox1, Noxo1, and Noxa1, produce superoxide in a GTP-dependent manner, which is abrogated by expression of a mutant Noxa1(R103E), defective in Rac binding. Superoxide production in Nox1-expressing HeLa and Caco-2 cells is decreased by depletion or sequestration of Rac; on the other hand, it is enhanced by expression of the constitutively active Rac1(Q61L), but not by that of a mutant Rac1 with the A27K substitution, deficient in binding to Noxa1. We also demonstrate that Nox1 activation requires membrane recruitment of Noxa1, which is normally mediated via Noxa1 binding to Noxo1, a protein tethered to the Nox1 partner p22(phox): the Noxa1-Noxo1 and Noxo1-p22(phox) interactions are both essential for Nox1 activity. Rac likely facilitates the membrane localization of Noxa1: although Noxa1(W436R), defective in Noxo1 binding, neither associates with the membrane nor activates Nox1, the effects of the W436R substitution are restored by expression of Rac1(Q61L). The Rac-Noxa1 interaction also serves at a step different from the Noxa1 localization, because the binding-defective Noxa1(R103E), albeit targeted to the membrane, does not support superoxide production by Nox1. Furthermore, a mutant Noxa1 carrying the substitution of Ala for Val-205 in the activation domain, which is expected to undergo a conformational change upon Rac binding, fully localizes to the membrane but fails to activate Nox1.
与膜上p22(phox)复合的非吞噬性产超氧化物NADPH氧化酶Nox1的激活需要其调节性可溶性蛋白Noxo1和Noxa1。然而,小GTP酶Rac的作用仍有待阐明。在此我们表明,Rac通过与Noxa1相互作用直接参与Nox1的激活。电穿孔的HeLa细胞异位表达Nox1、Noxo1和Noxa1,以GTP依赖的方式产生超氧化物,而这种方式可被有缺陷的、在Rac结合方面存在缺陷的突变体Noxa1(R103E)的表达所消除。通过消耗或隔离Rac,表达Nox1的HeLa和Caco-2细胞中超氧化物的产生会减少;另一方面,组成型活性Rac1(Q61L)的表达会增强超氧化物的产生,但与Noxa1结合存在缺陷的A27K替代突变体Rac1的表达则不会增强超氧化物的产生。我们还证明,Nox1的激活需要Noxa1的膜募集,这通常是通过Noxa1与Noxo1结合来介导的,Noxo1是一种与Nox1伴侣p22(phox)相连的蛋白:Noxa1-Noxo1和Noxo1-p22(phox)相互作用对于Nox1活性都是必不可少的。Rac可能促进Noxa1的膜定位:尽管在Noxo1结合方面存在缺陷的Noxa1(W436R)既不与膜结合也不激活Nox1,但Rac1(Q61L)的表达可恢复W436R替代的作用。Rac-Noxa1相互作用也发生在与Noxa1定位不同的步骤,因为尽管结合存在缺陷的Noxa1(R103E)靶向到膜上,但它并不支持Nox1产生超氧化物。此外,在激活结构域中用丙氨酸替代缬氨酸-205的突变体Noxa1,预计在与Rac结合时会发生构象变化,它完全定位到膜上但未能激活Nox1。